(19)
(11) EP 1 435 946 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
18.12.2013 Bulletin 2013/51

(45) Mention of the grant of the patent:
06.11.2013 Bulletin 2013/45

(21) Application number: 02773386.4

(22) Date of filing: 13.09.2002
(51) International Patent Classification (IPC): 
A61K 31/415(2006.01)
A61K 31/425(2006.01)
A61K 31/24(2006.01)
C07D 207/00(2006.01)
C07D 215/00(2006.01)
 A61K 31/42(2006.01)
A61K 31/40(2006.01)
A61K 31/216(2006.01)
C07D 209/02(2006.01)
C07D 233/00(2006.01)
(86) International application number:
PCT/US2002/029232
(87) International publication number:
WO 2003/024395 (27.03.2003 Gazette 2003/13)

(54)

LINKED BIARYL COMPOUNDS

VERKNÜPFTE BIARYL-VERBINDUNGEN

COMPOSES BIARYLES LIES

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

(30) Priority: 14.09.2001 US 322556 P
30.11.2001 US 335434 P
07.05.2002 US 378627 P
06.06.2002 US 386833 P

(43) Date of publication of application:
14.07.2004 Bulletin 2004/29

(73) Proprietors:
  • Amgen Inc.
    Thousand Oaks, CA 91320-1799 (US)
  • Japan Tobacco Inc.
    Takatsuki, Osaka 569-1125 (JP)

(72) Inventors:
  • ABE, Hiroyuki
    Osaka 569-1125 (JP)
  • HOUZE, Jonathan
    San Mateo, CA 94402 (US)
  • KAWASAKI, Hisashi
    Osaka 569-1125 (JP)
  • KAYSER, Frank
    San Francisco, CA 94114 (US)
  • SHARMA, Rajiv
    Fremont, CA 94555 (US)
  • SPERRY, Samuel
    San Diego, CA 92131 (US)

(74) Representative: HOFFMANN EITLE 
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München
81925 München (DE)


(56) References cited: : 
EP-A- 0 978 506
EP-A- 1 471 049
EP-A2- 0 359 169
WO-A-02/072539
WO-A1-01/00603
US-A- 4 443 536
 EP-A- 1 101 755
EP-A1- 1 431 284
WO-A-02/064550
WO-A-03/018515
US-A- 3 038 934
US-A- 4 466 902
   
  • PLATTNER, JACOB J. ET AL: "[[(Aminomethyl)aryl]oxy]acetic acid esters. A new class of high-ceiling diuretics. 2. Modifications of the oxyacetic side chain" JOURNAL OF MEDICINAL CHEMISTRY , 27(12), 1587-96 CODEN: JMCMAR; ISSN: 0022-2623, 1984, XP002357524
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).